Neurocrine Bio (NBIX) PT Raised to $96 at Piper Jaffray
Tweet Send to a Friend
Piper Jaffray analyst Charles C. Duncan reiterated an Overweight rating and boosted his price target on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE